Published on 9 Aug 2023 on Zacks via Yahoo Finance
Bionano Genomics, Inc. (BNGO) Reports Q2 Loss, Tops Revenue Estimates
Bionano Genomics, Inc. (BNGO) came out with a quarterly loss of $1.24 per share versus the Zacks Consensus Estimate of a loss of $0.90. This compares to loss of $1.10 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -37.78%. A quarter ago, it was expected that this company would post a loss of $0.90 per share when it actually produced a loss of $1.20, delivering a surprise of -33.33%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.